×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
This video will be soon available
Become an Oncostream member and receive full access to its content!
You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.
Registration Login
Registration Login
Ask a question
You must be registered on Oncostream to participate in chat
| 19:30 |
Opening
Prof. Dr. Eric Van Cutsem, UZ Leuven |
| 19:35 |
Current treatment landscape with anti-PD-1 therapy for advanced esophageal cancer
Prof. Dr. Marc Van den Eynde, Cliniques Universitaires Saint-Luc, Brussels |
| 20:00 |
GI immune related adverse events management with anti-PD-1 therapy Prof. Dr. Marc Peeters, UZ Antwerpen |
| 20:15 |
Pause
|
| 20:30 |
CPS testing in esophageal cancer Dr. Vasiliki Siozopoulou, UZ Antwerpen |
| 20h40 |
Q&A session Moderator: Prof. Dr. Eric Van Cutsem, UZ Leuven |
| 21:10 | Closing |
In collaboration with
MSD Belgium SRL / BV
Clos du Lynx, 5, Lynx Binnernhof - Bruxelles 1200 Brussel
Abbreviations:
UZ: Universitair Ziekenhuis
PD-1: Programmed death ligand 1
CPS: Combined Positive Score
Q&A: Questions and answers
Shooting date : 2021-10-11
Last update : 2021-10-25
Last update : 2021-10-25
Suggestions
There is no video available at the moment